elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50001044-3FF2A1AB-CA51-430C-B2CC-F64D57AD6A5A
Q50001044-3FF2A1AB-CA51-430C-B2CC-F64D57AD6A5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50001044-3FF2A1AB-CA51-430C-B2CC-F64D57AD6A5A
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.
P31
Q50001044-3FF2A1AB-CA51-430C-B2CC-F64D57AD6A5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50001044-3FF2A1AB-CA51-430C-B2CC-F64D57AD6A5A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a3fe8aa544917abb17de15760af04612dd47b5d8
P31
scholarly article